People who recover from mild COVID-19 have bone-marrow cells that can churn out antibodies for decades, although viral variants could dampen some of the protection they offer. Many people who have been infected with SARS-CoV-2 will probably make antibodies against the virus for most of their lives. Had COVID? You’ll probably make antibodies for a lifetime (May 26, 2021) In …
Whether it’s emotional or physical, many patients who have been infected with COVID-19 are living with long-term effects from the virus. Specialized support is available to anyone experiencing long COVID symptoms at Montefiore-Einstein’s COVID-19 Recovery Clinic (CORE). “Just as physical weakness is common, so too are challenges with thinking, anxiety, fear, loneliness, difficulty coping, and difficulty sleeping,” Aluko A. Hope, …
Older adults account for almost one-half of hospitalizations due to coronavirus disease 2019 (COVID-19). Providing post-acute rehabilitation for frail older adults recovering from COVID-19 remains a significant challenge as nursing facilities, one of the most common settings for post-acute care, have become overwhelmed by the COVID-19 pandemic. As the post-acute period is an essential window of opportunity for recovery, having …
In a recent article published in MedPage Today, medical experts at the American Academy of Neurology (AAN) annual meeting discussed COVID-19 vaccines and “long hauler” symptoms. “The question of vaccines and different neurological conditions has been studied over the years” said Walter Koroshetz, MD, director o the National institute of Neurological Disorders and Stroke (NINDS). “We don’t have any real …
Limited research has shown that the majority of patients who clear their infections of SARS-CoV-2 develop serum antibodies against the virus that last for at least several months but may decline over time. Although it has been speculated that the development of antibodies may be associated with a decreased risk of reinfection, the evidence for this hypothesis is limited and …
The effects of COVID-19 are highly variable, ranging from individuals who are asymptomatic to patients who develop severe acute respiratory distress syndrome, with potential involvement of almost all organs and systems. These acute symptoms have been well described since the first cohort studies that were published at the beginning of the pandemic. In a recent study of 478 patients who …
In a study published in JAMA Network, from April 21 to October 15, 2020, the post-acute care service assessed 381 white patients who had recovered from COVID-19 infection within 30-120 days, 166 (43.6%_ of whom were women with a mean age was 55.26. During acute COVID-19 illness, most patients were hospitalized, with a mean length of hospital stay of 18.41 …
